COPD Clinical Trials in Chicago, Illinois

4 studies are recruiting for copd in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

    A study taking place at multiple sites in the United States, Europe and Brazil to evaluate how well a new therapy for severe COPD/emphysema works, and how safe it is.

    Stage
    Not phased
    Ages
    22 and older
    Site
    Northwestern University, Chicago, Illinois
    Locations
    3 in total
    Run by
    Pulmair Medical, Inc.

    See if you can join NCT07119229 on ClinicalTrials.gov

  2. Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

    The objective of this study is to assess the safety and efficacy of Apreo BREATHE system when used to support native airways and release trapped air in the treatment of adult COPD patients with emphysema suffering from dyspnea due to hyperinflation despite optimal medical treatment. The Apreo BREAT…

    Stage
    Not phased
    Ages
    40 to 84
    Site
    University of Chicago, Chicago, Illinois
    Locations
    22 in total
    Run by
    Apreo Health, Inc.

    See if you can join NCT06891755 on ClinicalTrials.gov

  3. COPD Resources, Education, and Activity Designed for You Study

    Although COPD self-management treatment programs are effective in reducing COPD-related hospitalizations and increasing quality of life, there is a limited understanding of 'how and why' they work. The proposed research will use an engineering-inspired study design to identify effective COPD self-m…

    Stage
    Not phased
    Ages
    40 and older
    Site
    Rush University Medical Center, Chicago, Illinois
    Run by
    Rush University Medical Center

    See if you can join NCT07125053 on ClinicalTrials.gov

  4. myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

    Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at …

    Stage
    Not phased
    Ages
    30 and older
    Site
    University of Chicago, Chicago, Illinois
    Locations
    27 in total
    Run by
    Temple University

    See if you can join NCT05204888 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.